TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Lundbeck Pharma A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2020/12 |
Turnover |
24,083
|
24,001
|
27,086 |
Earnings before taxes |
3,274
|
3,060
|
-6,173 |
Total assets |
25,216
|
17,833
|
19,899 |
Current assets |
24,973
|
17,053
|
19,061 |
Current liabilities |
21,393
|
14,549
|
22,160 |
Equity capital |
3,823
|
6,568
|
-2,262 |
- share capital |
754
|
708
|
707 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2020/12 |
Solvency |
15.2%
|
36.8%
|
-11.4% |
Turnover per employee |
1,606
|
1,600
|
1,806 |
Profit as a percentage of turnover |
13.6%
|
12.7%
|
-22.8% |
Return on assets (ROA) | |||
Current ratio |
116.7%
|
117.2%
|
86.0% |
Return on equity (ROE) |
85.6%
|
46.6%
|
272.9% |
Change turnover |
-1,489
|
-3,126
|
2,652 |
Change turnover % |
-6%
|
-12%
|
11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.